Check patentability & draft patents in minutes with Patsnap Eureka AI!

pkd2 recombinant overexpression vector and its construction method and use

An overexpression vector and technology for use, applied in chemical instruments and methods, recombinant DNA technology, botany equipment and methods, etc., can solve problems such as lack of effective treatment and prevention of myocardial infarction

Active Publication Date: 2021-11-30
汉恒生物科技(上海)有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The problem in the prior art is the lack of means and methods that can effectively treat and prevent myocardial infarction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • pkd2 recombinant overexpression vector and its construction method and use
  • pkd2 recombinant overexpression vector and its construction method and use
  • pkd2 recombinant overexpression vector and its construction method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Example 1 Construction of adeno-associated virus vector and transforming embodiment

[0043] 1, pHBAd-EF1-MCS-CMV-EGFP vector (e.g. figure 1 ) With BamHI, EcoRI digestion, digestion system as follows:

[0044]

[0045] 2, the carrier recovery is completed digested.

[0046] 3, PKD2 PCR fragment recovered

[0047] PCR amplification PKD2 sequence system (50 l) as, wherein the forward primer sequence as shown in SEQ ID NO.2,

[0048] Primer sequences inverting NO.3 as shown in SEQ ID.

[0049] Table 2

[0050]

[0051] PCR program: Table 3

[0052]

[0053] The object of the fragments were obtained by gel electrophoresis, such as gel electrophoresis of PCR products wherein figure 2 Indicated.

[0054] 4, the carrier Deal fragment ligation reaction (20μl):

[0055] Table 4

[0056]

[0057] The above reaction system was placed in a hot bath at 50 deg.] C 20min, not immediately after the completion of the reaction as the subsequent reaction sample operations may be tempo...

Embodiment 2

[0063] Injection of recombinant adeno-associated virus vectors myocardial infarction model rats improve symptoms in mice

[0064] 1 Experimental Materials

[0065] C57BL / 6 mice (available from Shanghai SLAC Laboratory Animal Co., Ltd.).

[0066] 2, experimental method

[0067] 2.1 MI modeling mice

[0068] Take 24 mice, in which 12 is set in operation between the second and third rib lateral cut of the skin, the chest is exposed. Muscle incision between the second and third ribs, the ribs into the distractor, exposing the heart, left heart fixed exposure atrial, right hand holding the needle holder, with a 8-0 nylon thread 3-5mm LAD at the edge of the appendage ligation, and the other 12 for the sham group, only open chest, not surgery.

[0069] Intravenous injection of 2.2 HBAAV-EF1-PKD2-CMV-EGFP control and adeno-associated virus

[0070] 5 using a needle syringe, injected per mouse 1x10 11 v.g adeno-associated virus, adeno-associated virus control AAV-GFP (green fluorescent p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a PKD2 recombinant overexpression vector and its construction method and application. The PKD2 recombinant overexpression vector is obtained by inserting the target gene PKD2 into an adeno-associated virus vector, and the adeno-associated virus vector at least includes the following operably linked sequences Elements: EF1 promoter, MCS region, CMV promoter sequence, EGFP gene sequence. The PKD2 recombinant overexpression vector can express PKD2 efficiently. After in-depth research by the inventors, it was unexpectedly found that the PKD2 recombinant overexpression vector can alleviate the symptoms of myocardial infarction in mice. Injecting the adeno-associated virus carrying the gene into the mice with myocardial infarction can effectively restore the heart function of the mice, and the area of ​​myocardial infarction is significantly reduced, indicating that the technical solution of the present invention is suitable for the treatment of myocardial infarction.

Description

Technical field [0001] The present invention relates to a PKD2 recombinant overexpression carrier and its construction methods and use, belonging to the field of biotechnology. Background technique [0002] The gene standard reference sequence of PKD2 is GeneBank NM_000297.3, and PKD2 is located in 4Q21-23, gene length 68KB, contains 15 exons, coding region length 2907 bp. [0003] The prevalence of cardiovascular disease in my country is in the continuous rising stage, with approximately 2 million new intraocular infarction patients, increasing at 10.42% per year, and has become the main cause of heart failure and cardiovascular mortality rise rates and serious hazards One of the difficult diseases of the health of the people. Those skilled in the art have always been committed to the development of technologies that can effectively treat or prevent myocardial infarction. Problems in the prior art are missing methods and methods that can be effectively treated and prevent myocar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/864C12N5/10C12N15/66A61K48/00A61K38/17A61P9/10
CPCA61K38/1709A61K48/0025A61K48/005A61P9/10C07K14/47C12N15/66C12N15/86C12N2750/14143
Inventor 陈意雄蔡晓龙邹杰朱鹏飞白易鑫
Owner 汉恒生物科技(上海)有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More